151 related articles for article (PubMed ID: 7920160)
21. NYU Bluestone Center Receives Award to Study Oral Cancer Pain.
N Y State Dent J; 2015; 81(5):65. PubMed ID: 26521331
[No Abstract] [Full Text] [Related]
22. The molecular biology of oral carcinogenesis: toward a tumor progression model.
Todd R; Donoff RB; Wong DT
J Oral Maxillofac Surg; 1997 Jun; 55(6):613-23; discussion 623-5. PubMed ID: 9191644
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic applications of catalytic antisense RNAs (ribozymes).
Rossi JJ
Ciba Found Symp; 1997; 209():195-204; discussion 204-6. PubMed ID: 9383577
[TBL] [Abstract][Full Text] [Related]
24. Molecular targeting: the new challenge in lung cancer prevention.
Pastorino U
J Natl Cancer Inst; 2001 Aug; 93(16):1190-1. PubMed ID: 11504755
[No Abstract] [Full Text] [Related]
25. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.
Choi S; Myers JN
J Dent Res; 2008 Jan; 87(1):14-32. PubMed ID: 18096889
[TBL] [Abstract][Full Text] [Related]
26. A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins.
Cooper D; Penny R; Symonds G; Carr A; Gerlach W; Sun LQ; Ely J
Hum Gene Ther; 1999 May; 10(8):1401-21. PubMed ID: 10365669
[No Abstract] [Full Text] [Related]
27. Papillomaviruses as targets for cancer gene therapy.
Shillitoe EJ
Cancer Gene Ther; 2006 May; 13(5):445-50. PubMed ID: 16341140
[TBL] [Abstract][Full Text] [Related]
28. Efficient nonviral gene therapy with FasL and Del1 fragments in mice.
Kitano H; Mamiya A; Kokubun S; Hidai C
J Gene Med; 2012 Nov; 14(11):642-50. PubMed ID: 23136083
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy in dentistry: a review.
Shilpashree HS; Sarapur S
N Y State Dent J; 2013; 79(5):60-4. PubMed ID: 24245465
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated gene transfer of antisense ribozyme for alpha (1,3)galactosyltransferase gene and alpha (1,2)fucosyltransferase gene in xenotransplantation.
Hayashi S; Nagasaka T; Katayama A; Saito I; Hamada H; Kobayashi T; Yokoyama I; Ohtsuka S; Uchida K; Takagi H
Transplant Proc; 1997 Jun; 29(4):2213. PubMed ID: 9193597
[No Abstract] [Full Text] [Related]
31. The potential applications of gene transfer in the treatment of patients with cancer: a concise review.
Hussein AM
Cancer Invest; 1996; 14(4):343-52. PubMed ID: 8689430
[No Abstract] [Full Text] [Related]
32. PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
Yu D; Wang A; Huang H; Chen Y
Nanomedicine (Lond); 2008 Dec; 3(6):813-21. PubMed ID: 19025455
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy strategies for novel cancer therapeutics.
Rosenfeld ME; Curiel DT
Curr Opin Oncol; 1996 Jan; 8(1):72-7. PubMed ID: 8868104
[TBL] [Abstract][Full Text] [Related]
34. [Progress of antisense technology applied in metabolic regulation of bacteria].
Li Q; Xu X; Yang J; Nie Q; Xian M
Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1689-94. PubMed ID: 19149178
[TBL] [Abstract][Full Text] [Related]
35. Antisense gene expression in yeast.
Atkins D; Arndt GM; Izant JG
Biol Chem Hoppe Seyler; 1994 Nov; 375(11):721-9. PubMed ID: 7695834
[TBL] [Abstract][Full Text] [Related]
36. Delivery of recombinant HIV-1-directed antisense and ribozyme genes.
Sczakiel G; Palú G; James W
Methods Mol Biol; 1997; 63():389-400. PubMed ID: 9113664
[No Abstract] [Full Text] [Related]
37. Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes.
Ramezani A; Ma XZ; Ameli M; Arora A; Joshi S
Front Biosci; 2006 Sep; 11():2940-8. PubMed ID: 16720366
[TBL] [Abstract][Full Text] [Related]
38. Cloning strategies for catalytic antisense RNAs.
Tabler M; Tsagris M
Methods Mol Biol; 1997; 74():121-9. PubMed ID: 9204427
[No Abstract] [Full Text] [Related]
39. Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation.
Sugerman PB; Joseph BK; Savage NW
Oral Dis; 1995 Sep; 1(3):172-88. PubMed ID: 8705824
[TBL] [Abstract][Full Text] [Related]
40. Antisense strategies come of age. Antisense strategies sponsored by the New York Academy of Sciences, Philadelphia, PA, USA, January 12-15, 1992.
Denhardt DT
New Biol; 1992 May; 4(5):473-81. PubMed ID: 1515412
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
